AVP and cerebral infarction: Due to the great harm of cerebral infarction and limited treatment methods, a prospective randomized clinical case-control study was conducted to investigate the prognosis of the prophylactic use of the antidepressant escitalopram in acute cerebral infarction and its effect on the plasma copeptin levels in order to provide both a relevant theoretical basis and guidance for clinical treatment.